by sjenkins1 | Apr 15, 2025 | Uncategorized
Boston, MA. 15th April 2025 MaineHealth has adopted contingency management (CM) as an evidence-based strategy for treating stimulant use disorder. Contingency Management Innovations (CMI), the CM division of Q2i, offers advanced technology to address stimulant use...
by sjenkins1 | Mar 11, 2025 | Uncategorized
Boston, MA – 11 March 2025 Q2i today announced its pivotal role in the successful rollout of the Recovery Incentives Program: California’s Contingency Management benefit for stimulant use disorder treatment. Powered by Q2i’s advanced State Incentive Management System...
